January 11-14, 2027 | San Francisco Marriott Marquis
January 15, 2027 | Virtual
January 11-14, 2027 | San Francisco
January 15, 2027 | Virtual
January 11-14, 2027 | San Francisco Marriott Marquis
January 15, 2027 | Virtual
2027 Participating Companies
RejuvenRx Inc.
RejuvenRx Inc. is an early stage biotech company leveraging its world-leading expertise in stem cell biology and the CoREST complex to develop first-in-class CoREST molecular glue degraders as disease-modifying medicines in hematology, oncology and aging.